Sony, Olympus set up medical joint venture

TOKYO, Japan - Toru Katsumoto (L), president of Sony Olympus Medical Solutions Inc., shakes hands with Takashi Fukaya, executive vice president of the new company, at a press conference in Tokyo on April 16, 2013. Sony Olympus Medical Solutions is a joint venture formally established the same day by merging the medical businesses of Sony Corp. and Olympus Corp., with an eye to marketing new endoscopes and other medical equipment.

Sample
PDF Preview

Product Code
ILEA001181431

Registered date
2013/4/16 00:00:00

Credit
Kyodo / Kyodo News Images

Media source
2013 Kyodo News

Media size
3204 × 2525 pixel

Resolution
240 dpi

Deployment size
735.73(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Research to start on blood tests to detect 13 cancer types

TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.

Novartis management replaced

TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.

Novartis management replaced

TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.

Food chain president shot dead

KYOTO, Japan - Photo taken in Kyoto's Yamashina Ward on Dec. 19, 2013, shows the site (L back) where Takayuki Ohigashi, president of Ohsho Food Service Corp., was shot earlier the same day. The president of the company, which operates a Chinese dumpling restaurant chain under the "Gyoza no Ohsho" brand in Japan, was found lying in a parking lot in front of the company's head office (seen at the right) just before 7 a.m. and was confirmed dead after being taken to hospital, according to the Kyoto prefectural police.

Amari to miss key TPP talks due to cancer treatment

TOKYO, Japan - Akira Amari, Japan's minister in charge of the Trans-Pacific Partnership free trade talks, announces at a press conference at the Cabinet Office in Tokyo on Dec. 5, 2013, that he will not be able to attend a TPP ministerial negotiating session starting Dec. 7 in Singapore, as he has been diagnosed with tongue cancer. Tokyo will send Amari's deputy, Yasutoshi Nishimura, senior vice minister of the Cabinet Office, instead to the four-day meeting.

Japan Tobacco to undertake drastic restructuring

TOKYO, Japan - Japan Tobacco Co. Vice President Akira Saeki speaks at a news conference in Tokyo on Oct. 30, 2013, as the company said it will close four of its nine cigarette manufacturing-related factories in Japan and a vending machine production base, most of them in March 2015, and cut 1,600 jobs, or about 20 percent of the employees in its tobacco business, due to falling sales.

Novartis scandal

TOKYO, Japan - David Epstein (L), division head at Novartis AG, the Swiss-based pharmaceutical giant, speaks in a press conference in Tokyo on Oct. 3, 2013. At right is Yoshiyasu Ninomiya, president of Novartis Pharma K.K., a Japanese unit of Novartis AG. Novartis Pharma K.K. has allegedly engaged in deceptive advertizing for the blood pressure-lowering drug Diovan by citing a study based on manipulated clinical data.

Robot Suit HAL

TSUKUBA, Japan - Cyberdyne Inc. CEO Yoshiyuki Sankai (L) explains his venture company's product, medical Robot Suit HAL, (R) worn by an employee in Tsukuba, Ibaraki Prefecture, near Tokyo on Aug 5, 2013. HAL was recognized by a German certification body as a medical device that may be sold for rehabilitation assistance throughout the entire European Union, according to the company.

Novartis Pharma

TOKYO, Japan - Yoshiyasu Ninomiya, president of Novartis Pharma K.K., attends a press conference in Tokyo on July 29, 2013. Novartis Pharma, a Japanese unit of Swiss drug company Novartis AG, said it has found no evidence a former employee manipulated or altered clinical research data for the drugmaker's Diovan blood pressure lowering drug.

Kanebo skin-whitening product users report serious symptoms

TOKYO, Japan - Masumi Natsusaka, president of Kanebo Cosmetics Inc., speaks at a news conference in Tokyo on July 23, 2013. The company said that 2,250 users of its skin-whitening cosmetics have reported developing serious symptoms such as white blotches on their skin since it began a recall of 54 products on July 4.